Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001171520-22-000460
Filing Date
2022-08-19
Accepted
2022-08-19 16:30:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 eps10444_jds.htm SC 13D/A 131712
2 COOPERATION AGREEMENT, DATED AS OF AUGUST 18, 2022 ex99-1.htm EX-99 97018
  Complete submission text file 0001171520-22-000460.txt   230058
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 221181222
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 FLETCHER AVENUE SUITE 501 FORT LEE NJ 07024
Business Address
SINGER JULIAN D. (Filed by) CIK: 0001628706 (see all company filings)

Type: SC 13D/A